Dr. Sarah E. Umetsu, MD

Dr. Umetsu practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Umetsu's NPI, 1265798383, was assigned on April 3, 2012. Dr. Umetsu graduated from Feinberg School of Medicine in 2012. Dr. Umetsu holds California license NONE.

Dr. Umetsu's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Umetsu's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Umetsu is also affiliated with UCSF Health Stanyan Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Umetsu to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Umetsu practices, 5 sites in all. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Umetsu's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Umetsu is board certified in pathology - anatomic by the American Board of Pathology. Dr. Umetsu is licensed in California.

CMS data shows 579 Medicare services from Dr. Umetsu across 7 procedure codes in 2024, for 237 Medicare patients. Medicare paid $20,165 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 237 Medicare patients who saw Dr. Umetsu in 2024. The largest group is 65 to 74, with 127 patients. 70% of them have high blood pressure, and 68% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Umetsu's median patient age at 56, with 50% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Umetsu for performance year 2024, reported as part of a group. Dr. Umetsu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 41 papers to Dr. Umetsu, published from 2007 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Liver Neoplasms, Membrane Proteins and Carcinoma, Hepatocellular. Dr. Umetsu has published most often in Histopathology. Dr. Umetsu's most frequent co-authors are Nancy Mostafa Joseph, MD, Gregory Richard Bean, MD, PhD and Sanjay Kakar, MD.

CMS Open Payments shows 15 general payments to Dr. Umetsu from 1 drug or device company from 2023 to 2025. Consulting fees make up the largest share, 100% of the total. Exact Sciences Corporation paid the most, $32,476.

Dr. Umetsu graduated from Feinberg School of Medicine in 2012.

Dr. Umetsu is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.